Medicines Discovery Catapult to promote UK cell and gene therapy research

The UK’s Medicines Discovery Catapult is joining forces with the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS) at the University of Liverpool in a new research collaboration based around cell and gene therapy technologies.

The government-funded organization is collaborating with the aim of making the platforms available to small and medium sized British drug discovery firms.

The research will focus on identifying and establishing projects focused on the development of human 3D cell models and robust cellular platforms.